Company news

SELLAS Life Sciences Group, Inc. news in 2021

SELLAS Life Sciences Group, Inc.'s news releases, calls and decks from 2021, newest first.

View company

SELLAS Life Sciences Announces Final Court Approval of Settlement of Derivative Litigation

November 22, 2021

SELLAS Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update

November 11, 2021

SELLAS Life Sciences Announces Settlement of Derivative Litigation

September 22, 2021

SELLAS Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update

August 11, 2021

SELLAS Life Sciences to Host Virtual Investor Symposium on its Lead Asset, Galinpepimut-S, on August 17, 2021

July 27, 2021

SELLAS Reports Encouraging Updated Clinical Data from Ongoing Mesothelioma Study of Galinpepimut-S (GPS) Combined with Opdivo

June 23, 2021

SELLAS Life Sciences Announces Inclusion in Russell Microcap® Index

June 21, 2021

SELLAS Life Sciences Announces USPTO Decision to Grant New Patent for Galinpepimut-S in Combination with Checkpoint Inhibitor Therapies

May 26, 2021

SELLAS Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update

May 12, 2021

SELLAS Life Sciences Reports Full Year 2020 Financial Results and Provides Business Update

March 22, 2021

Decks in 2021